Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1971 1
1981 1
1990 1
1992 2
1995 1
1999 2
2000 2
2003 1
2005 4
2006 4
2007 1
2008 3
2009 6
2010 7
2011 13
2012 10
2013 13
2014 11
2015 12
2016 11
2017 8
2018 11
2019 23
2020 21
2021 24
2022 10
2023 21
2024 20
2025 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

230 results

Results by year

Filters applied: . Clear all
Page 1
Benefits and Harms of Breast Cancer Screening: A Systematic Review.
Myers ER, Moorman P, Gierisch JM, Havrilesky LJ, Grimm LJ, Ghate S, Davidson B, Mongtomery RC, Crowley MJ, McCrory DC, Kendrick A, Sanders GD. Myers ER, et al. Among authors: ghate s. JAMA. 2015 Oct 20;314(15):1615-34. doi: 10.1001/jama.2015.13183. JAMA. 2015. PMID: 26501537
Milia en plaque.
Avhad G, Ghate S, Dhurat R. Avhad G, et al. Among authors: ghate s. Indian Dermatol Online J. 2014 Oct;5(4):550-1. doi: 10.4103/2229-5178.142573. Indian Dermatol Online J. 2014. PMID: 25396166 Free PMC article. No abstract available.
Screening mammography for average-risk women.
Kaunitz AM, Pinkerton JV, Ghate SV, Wolf AMD. Kaunitz AM, et al. Among authors: ghate sv. Menopause. 2018 Mar;25(3):343-345. doi: 10.1097/GME.0000000000001026. Menopause. 2018. PMID: 29257034 Review.
Patient-reported Outcomes in KEYLYNK-010: Pembrolizumab Plus Olaparib Versus Abiraterone or Enzalutamide for Participants with Biomarker-unselected, Previously Treated Metastatic Castration-resistant Prostate Cancer.
Mehra N, Antonarakis ES, Park SH, Goh JC, McDermott R, Sala Gonzalez N, Fong PC, Greil R, De Santis M, Yanez PE, Huang YH, Begbie SD, Rey F, Kramer G, Suzuki H, Saretsky TL, Ghate SR, Cui Y, Hosius C, Yu EY. Mehra N, et al. Among authors: ghate sr. Eur Urol Oncol. 2025 Aug;8(4):1030-1040. doi: 10.1016/j.euo.2025.04.018. Epub 2025 Jul 19. Eur Urol Oncol. 2025. PMID: 40685311 Free article. Clinical Trial.
Bowen's disease: An unusual clinical presentation.
Dandale A, Mantri MD, Thakkar V, Dhurat RS, Ghate S. Dandale A, et al. Among authors: ghate s. Indian Dermatol Online J. 2014 Oct;5(4):526-8. doi: 10.4103/2229-5178.142546. Indian Dermatol Online J. 2014. PMID: 25396151 Free PMC article. No abstract available.
The Additional Costs per Month of Progression-Free Survival and Overall Survival: An Economic Model Comparing Everolimus with Cabozantinib, Nivolumab, and Axitinib for Second-Line Treatment of Metastatic Renal Cell Carcinoma.
Swallow E, Messali A, Ghate S, McDonald E, Duchesneau E, Perez JR. Swallow E, et al. Among authors: ghate s. J Manag Care Spec Pharm. 2018 Apr;24(4):335-343. doi: 10.18553/jmcp.2018.24.4.335. J Manag Care Spec Pharm. 2018. PMID: 29578848 Free PMC article.
230 results